Zdrowie i gospodarka · 27/06/2012

FDA Withdraws Guidance on Lupus Nephritis Treatment, Citing Systemic Lupus Erythematosus

The Food and Drug Administration (FDA) is withdrawing a guidance document related to the development of medical products for treating lupus nephritis caused by systemic lupus erythematosus, published in the Federal Register on June 22, 2010.